研報掘金丨信達證券:維持工業富聯“買入”評級,AI業務持續釋放業績
信達證券研報指出,工業富聯預計Q2歸母淨利潤同比增長約50%,AI業務持續釋放業績。公司產品結構持續優化,產品量產加速爬坡,客户對AI數據中心Hyper-scaleAI機櫃產品需求不斷增加。其中,AI服務器營收同比增長超60%,雲服務商服務器營收同比增長超1.5倍。公司在大客户的核心產品份額繼續保持領先優勢,先進AI算力的GPU模塊及GPU算力板等產品的出貨,在Q2實現顯著增長。高速交換機方面,在AI需求持續提升的驅動下,公司產品結構持續改善,Q2800G交換機的營收達2024全年的3倍。公司系算力鏈核心個股,看好公司在該領域的發展前景,維持對公司的“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.